MedPath

An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.

Not Applicable
Completed
Conditions
Candidiasis, Oral
HIV Infections
Registration Number
NCT00002133
Lead Sponsor
Janssen, LP
Brief Summary

To assess the efficacy and safety of itraconazole oral solution in HIV-seropositive patients with oropharyngeal candidiasis that is refractory to fluconazole.

Detailed Description

Patients receive itraconazole oral solution twice daily. Per 08/15/94 amendment, patients with complete resolution of oropharyngeal candidiasis lesions upon completion of treatment are eligible for maintenance treatment on protocol FDA 236C. Patients who decline maintenance are followed for 6 weeks. Patients who relapse during follow-up are re-treated for 14-28 days; if lesions clear, patients may enter the maintenance protocol.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (18)

Univ of Alabama at Birmingham

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

Univ of Arkansas for Med Sciences

πŸ‡ΊπŸ‡Έ

Little Rock, Arkansas, United States

East Bay AIDS Ctr

πŸ‡ΊπŸ‡Έ

Berkeley, California, United States

Kaiser Permanente Med Ctr

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

Dr Douglas Ward

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

George Washington Univ Med Ctr

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Veterans Administration Med Ctr

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Infectious Diseases Research Clinic / Indiana Univ Hosp

πŸ‡ΊπŸ‡Έ

Indianapolis, Indiana, United States

Natl Inst of Allergy & Infect Dis / Cln Ctr

πŸ‡ΊπŸ‡Έ

Bethesda, Maryland, United States

Ann Arbor Veterans Administration Med Ctr

πŸ‡ΊπŸ‡Έ

Ann Arbor, Michigan, United States

Scroll for more (8 remaining)
Univ of Alabama at Birmingham
πŸ‡ΊπŸ‡ΈBirmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.